ADVISORY BOARD AGREEMENTAdvisory Board Agreement • June 3rd, 2022 • BioLife4D Corp • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledJune 3rd, 2022 Company Industry JurisdictionTHIS ADVISORY BOARD AGREEMENT (this “Agreement”) is entered into on August 28, 2017 (the “Effective Date”) by and between BIOLIFE4D Corporation, a Delaware corporation (the “Company”), and Dr. Raimond Winslow (“Advisor”).
ADVISORY BOARD AGREEMENTAdvisory Board Agreement • June 3rd, 2022 • BioLife4D Corp • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledJune 3rd, 2022 Company Industry JurisdictionTHIS ADVISORY BOARD AGREEMENT (this “Agreement”) is entered into on Jan 21, 2019 (the “Effective Date”) by and between BIOLIFE4D Corporation, a Delaware corporation (the “Company”), and Stephen M. Simes (“Advisor”).
ADVISORY BOARD AGREEMENTAdvisory Board Agreement • June 3rd, 2022 • BioLife4D Corp • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledJune 3rd, 2022 Company Industry JurisdictionTHIS ADVISORY BOARD AGREEMENT (this “Agreement’) is entered into on May 30, 2017 (the “Effective Date”) by and between BIOGEN3D Corporation, a Delaware corporation (the “Company’), and Sean Palecek (“Advisor”).
ADVISORY BOARD AGREEMENTAdvisory Board Agreement • June 3rd, 2022 • BioLife4D Corp • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledJune 3rd, 2022 Company Industry JurisdictionTHIS ADVISORY BOARD AGREEMENT (this “Agreement”) is entered into on June 8, 2017 (the “Effective Date”) by and between BIOGEN3D Corporation, a Delaware corporation (the “Company”), and Janet Zoldan (“Advisor”).
ADVISORY BOARD AGREEMENTAdvisory Board Agreement • June 3rd, 2022 • BioLife4D Corp • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledJune 3rd, 2022 Company Industry JurisdictionTHIS ADVISORY BOARD AGREEMENT (this “Agreement”) is entered into on July 11, 2017 (the “Effective Date”) by and between BIOLIFE4D Corporation, a Delaware corporation (the “Company”), and Dr. Shayn Peirce-Cottler (“Advisor”).